Global Candidiasis Trials Review Market Analysis Report 2015 Radiant Insights, Inc
Summary GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015"" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. View summary of this report @ http://www.radiantinsights.com/research/candidiasis-global-clinical-trials-review-h1-2015 Scope The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months Reasons to buy Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level
Summary
GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015"" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-global-clinical-trials-review-h1-2015
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by The University of Melbourne,<br />
<strong>2015</strong>* 57<br />
List of Figures<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />
View summary of this report @ http://www.radiantinsights.com/research/candidiasis-globalclinical-trials-review-h1-<strong>2015</strong><br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, Middle East and Africa, Top Five Countries (%), <strong>2015</strong>* 13<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, Central and South America, Top Five Countries (%), <strong>2015</strong>* 14<br />
Proportion of <strong>Candidiasis</strong> to Infectious Disease Clinical <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />
<strong>Candidiasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />
<strong>Candidiasis</strong> Therapeutics, G7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />
Proportion of <strong>Candidiasis</strong> to Infectious Disease Clinical <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />
<strong>Candidiasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />
<strong>Candidiasis</strong> Therapeutics, E7 Countries, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 21<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 22<br />
<strong>Candidiasis</strong> Therapeutics, <strong>Global</strong>, Clinical <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target Trends, 2010-2014 29<br />
<strong>Candidiasis</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, Clinical <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 30<br />
<strong>Candidiasis</strong> Therapeutics Clinical <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 31
Change language